News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Companies Such As Actavis (ACT) Find Ways To Flee Taxes And Make CEOs Richer While At It


1/27/2014 7:17:49 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Ten years ago, Congress passed a law intended to penalize chief executive officers whose companies shift their legal addresses to tax havens. It hasn’t worked out as planned. Companies have found ways around the law that create new rewards for executives. When Actavis Inc. (ACT:US) changed its incorporation to Ireland in October, the New Jersey-based drugmaker helped CEO Paul Bisaro avoid the law’s bite by handing him more than $40 million of stock as much as three years ahead of its schedule, then promising him an additional $5 million to remain with the company.

Help employers find you! Check out all the jobs and post your resume.

Read at BusinessWeek


comments powered by Disqus
Actavis
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES